Drugs / Lysostaphin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06791746 | Jan 2020 → Dec 2021 | disease related to hematopoietic stem cell transplant, mouth disorder | Zhejiang University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lysostaphin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06791746 ↗ |
| Modality | Protein / enzyme biologic | “Lysostaphin is a proteolytic enzyme produced by a specific species of Staphylococcus” NCT06791746 ↗ |